SMTL ID : 9dmv.1

Human muscle nAChR with fab9-bound

Coordinates

PDB Format Compare

Method

ELECTRON MICROSCOPY

Oligo State

hetero-2-1-1-1-1-1-mer

Ligands

4 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose

NAG-NAG-BMA-MAN-MAN.1: 10 residues within 4Å: Chain A: N.161, S.163, R.202, W.204, K.205, H.206, S.207, T.222, H.224, V.226 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:S.207, A:S.207, A:W.204, A:H.206 NAG-NAG-BMA-MAN-MAN.2: 10 residues within 4Å: Chain B: N.161, S.163, E.200, W.204, K.205, H.206, S.207, T.222, H.224, V.226 1 PLIP interactions: 1 interactions with chain B Hydrogen bonds: B:S.207, B:S.207, B:H.206 NAG-NAG-BMA-MAN-MAN.3: 13 residues within 4Å: Chain C: W.162, N.164, T.166, I.218, I.236, Y.238, I.240, P.496, D.498, P.499, F.500, P.501, S.502 3 PLIP interactions: 3 interactions with chain C Hydrophobic interactions: C:I.218 Hydrogen bonds: C:Y.238, C:F.500 NAG-NAG-BMA-MAN-MAN.4: 14 residues within 4Å: Chain D: W.162, N.164, S.166, R.219, N.221, D.223, P.224, R.225, Y.239, I.241, P.498, P.501, F.502, P.503 2 PLIP interactions: 2 interactions with chain D Hydrogen bonds: D:R.225, D:Y.239, D:P.503

1 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose

NAG-NAG-BMA-MAN.5: 10 residues within 4Å: Chain E: W.159, N.161, S.163, V.213, R.215, I.231, S.233, I.235, P.483, L.485 No protein-ligand interaction detected (PLIP)

1 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG-NAG.6: 5 residues within 4Å: Chain E: Y.83, N.86, S.88, G.133, G.134 No protein-ligand interaction detected (PLIP)

4 x POV: (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate(Non-covalent)

POV.7: 18 residues within 4Å: Chain A: F.247, Y.254, F.345, F.346 Chain C: F.321, I.324, L.325, V.328, L.332, R.335, P.343, W.345, V.346, F.350, W.460, V.467, L.470, F.471 7 PLIP interactions: 1 interactions with chain A, 6 interactions with chain C Hydrophobic interactions: A:F.247, C:V.328, C:V.328, C:F.350, C:F.471, C:F.471 Salt bridges: C:R.335 POV.11: 17 residues within 4Å: Chain C: L.261, F.265, Y.268 Chain D: M.322, V.325, I.326, I.329, I.333, R.336, H.341, S.344, V.347, F.351, W.462, V.465, V.469, C.473 13 PLIP interactions: 11 interactions with chain D, 2 interactions with chain C Hydrophobic interactions: D:M.322, D:V.325, D:I.326, D:I.329, D:I.329, D:I.333, D:V.347, D:F.351, D:F.351, C:F.265, C:F.265 Salt bridges: D:R.336, D:R.336 POV.14: 18 residues within 4Å: Chain C: L.246, L.249, V.250, I.253, A.254, I.257, F.487 Chain D: T.156, A.305, I.306, K.311, L.314, F.315, V.318, L.319, M.322, I.488 Ligands: CLR.8 10 PLIP interactions: 2 interactions with chain C, 8 interactions with chain D Hydrophobic interactions: C:A.254, C:I.257, D:K.311, D:L.314, D:L.314, D:F.315, D:F.315, D:V.318, D:L.319 Hydrogen bonds: D:I.306 POV.17: 25 residues within 4Å: Chain A: I.306, I.310, V.313, I.314, N.317, R.321, H.326 Chain E: V.252, L.253, G.256, L.257, L.259, L.260, Y.262, F.263, L.264, P.265, A.266, K.272, N.452, D.455, F.459, W.460, L.463, F.466 11 PLIP interactions: 3 interactions with chain A, 8 interactions with chain E Hydrophobic interactions: A:I.310, E:V.252, E:L.259, E:F.263, E:F.263, E:F.263, E:F.459, E:F.466 Hydrogen bonds: A:N.317 Salt bridges: A:H.326, E:D.455

6 x CLR: CHOLESTEROL(Non-covalent)

CLR.8: 11 residues within 4Å: Chain C: I.257, L.261, I.264, T.479, S.480, T.483, L.484, F.487, L.488, T.491 Ligands: POV.14 4 PLIP interactions: 4 interactions with chain C Hydrophobic interactions: C:I.257, C:L.484, C:F.487, C:T.491 CLR.10: 11 residues within 4Å: Chain B: L.299, V.303, I.306, A.307, I.310 Chain D: L.247, I.250, I.251, V.255, L.259 Ligands: CLR.13 6 PLIP interactions: 3 interactions with chain D, 3 interactions with chain B Hydrophobic interactions: D:I.250, D:I.251, D:L.259, B:L.299, B:V.303, B:I.310 CLR.12: 10 residues within 4Å: Chain D: V.258, F.262, V.482, T.485, A.486, F.489, L.490, V.493, Y.494 Ligands: CLR.13 6 PLIP interactions: 6 interactions with chain D Hydrophobic interactions: D:F.262, D:F.262, D:T.485, D:L.490, D:V.493, D:V.493 CLR.13: 12 residues within 4Å: Chain D: F.160, P.246, I.250, L.254, V.255, V.258, L.259, F.262, F.489, V.493 Ligands: CLR.10, CLR.12 9 PLIP interactions: 9 interactions with chain D Hydrophobic interactions: D:F.160, D:F.160, D:I.250, D:I.250, D:L.254, D:V.255, D:V.258, D:F.489, D:V.493 CLR.15: 10 residues within 4Å: Chain E: T.153, Y.154, S.300, V.301, R.306, F.310, G.469, L.472, I.473 Ligands: CLR.16 2 PLIP interactions: 2 interactions with chain E Hydrophobic interactions: E:T.153, E:I.473 CLR.16: 11 residues within 4Å: Chain B: L.232, V.236, I.240 Chain E: L.299, S.300, V.301, R.306, I.309, F.310, V.313 Ligands: CLR.15 4 PLIP interactions: 3 interactions with chain E, 1 interactions with chain B Hydrophobic interactions: E:V.301, E:I.309, E:V.313, B:L.232

1 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG.9: 4 residues within 4Å: Chain B: R.46 Chain D: E.93, G.96, N.97 No protein-ligand interaction detected (PLIP)

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Li, H. et al., Structure of human muscle AChR with fab9-bound. To Be Published

Release Date

2025-04-09

Peptides

Acetylcholine receptor subunit alpha: AB
Acetylcholine receptor subunit beta: C
Acetylcholine receptor subunit delta: D
Acetylcholine receptor subunit epsilon: E
Fab9 heavy chain: F
Fab9 light chain: G

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
C

C
E

D
D

E
B

F
F

G
G

Membrane

We predict this structure to be a membrane protein.
Show / Hide

Acetylcholine receptor subunit alpha

Acetylcholine receptor subunit beta

Acetylcholine receptor subunit delta

Acetylcholine receptor subunit epsilon

Fab9 heavy chain

Fab9 light chain

Related Entries With Identical Sequence